Cibus Reports Third Quarter Financial Results and Provides Business Update
Globe Newswire•12/11/2026•16:05 ET
0
Key Highlights
- ➤$10.7 million cash, funding planned operations and capex into early Q1 2027
- ➤$30.2 million nine-month operating cash burn, down 19% year-over-year
- ➤Rice traits performed well in Latin American trials; Interoc testing customer varieties
- ➤Biofragrance program targets approximately $100 million peak annual revenue across eight products
- ➤Net loss $21.9 million, improving from $24.3 million year-over-year
Expert Statements
Craig Wichner, Chief Executive Officer of Cibus
“Three months ago I described three ways our platform creates value: platform programs that generate revenue today, royalties as our traits reach acres, and partnerships that deepen over time. Each of these moved closer this quarter. We received requests from our customer for larger quantities of two biofragrance products to advance their product development. Our Rice traits performed well in Latin American field trials and are now being tested where it counts, in our customer Interoc's own varieties in its own fields. Further, a second partner-funded crop program, Mustard in India, began work in the quarter.”
Rice herbicide-tolerance traits performed well in Latin American field trials and are now being tested by customer Interoc in its own varieties
Initiated the manufacturing process for initial two biofragrance products; biofragrance program represents an estimated $100 million peak annual revenue opportunity with eight products currently identified for potential commercialization
Get started
Create a free account to read the full story.